Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Reumatología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
ClinicalTrials.gov
Anti-tnf Inhibitor Antibody-mediated Blockade Of Drug Efficacy In Rheumatoid Arthritis (Antibody-ra)
OBSERVATIONAL
Inicio: 1 de ene de 2014
ID: NCT01981473
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study With an Open-label Period and Long-term Extension to Assess the Efficacy and Safety of Rilzabrutinib in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)
INTERVENTIONAL
Inicio: 18 de ago de 2025
ID: NCT07086976
Completado
ClinicalTrials.gov
Upadacitinib Treatment Patterns, Achievement of Treatment Targets and Maintenance of Response in Moderate to Severe Rheumatoid Arthritis Patients in Real-World Practice (UPHOLD)
OBSERVATIONAL
Inicio: 16 de oct de 2020
ID: NCT04497597
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
INTERVENTIONAL
Inicio: 1 de mar de 2010
ID: NCT01061736
Completado
Fase 2
ClinicalTrials.gov
A Randomized, Double-Blind Phase 2b Study to Evaluate the Efficacy, Safety, and Tolerability of A 623 Administration in Subjects With Systemic Lupus Erythematosus
INTERVENTIONAL
Inicio: 1 de jul de 2010
ID: NCT01162681
Completado
Fase 2
ClinicalTrials.gov
A Phase 2b, Dose-ranging Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
INTERVENTIONAL
Inicio: 31 de mar de 2011
ID: NCT01283139
Reclutando
ClinicalTrials.gov
Prospective, Observational Study in Participants With Active Systemic Lupus Erythematosus (SLE) (Including Lupus Nephritis) With Inadequate Response to Glucocorticoids and At Least 2 Immunosuppressants
OBSERVATIONAL
Inicio: 8 de oct de 2025
ID: NCT07175285
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Open-label, Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Subjects With Rheumatoid Arthritis
INTERVENTIONAL
Inicio: 28 de feb de 2017
ID: NCT03025308
Completado
Fase 4
ClinicalTrials.gov
A Phase IV Study to Evaluate Decreased Dose Frequency in Patients With Systemic Juvenile Arthritis (SJIA) Who Experience Laboratory Abnormalities During Treatment With Tocilizumab
INTERVENTIONAL
Inicio: 10 de jun de 2013
ID: NCT01734382
Completado
ClinicalTrials.gov
A Prospective Observational Study To Evaluate Long-Term Safety And Functional Status Of Subjects With Rheumatoid Arthritis Previously Enrolled In Studies Of CP-690,550
OBSERVATIONAL
Inicio: 1 de abr de 2007
ID: NCT00414661
Terminado
Fase 3
ClinicalTrials.gov
Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.
INTERVENTIONAL
Inicio: 5 de sept de 2012
ID: NCT01682512
Activo, no recluta
ClinicalTrials.gov
Assessment of Guselkumab (Tremfya) and IL-17 Inhibitor Therapies in Patients With Psoriatic Arthritis in Routine Clinical Practice; A Prospective, Observational Cohort Study
OBSERVATIONAL
Inicio: 25 de ago de 2021
ID: NCT05049798
Completado
Fase 2
ClinicalTrials.gov
A Multicenter, Randomized, Double-blind, Placebo Controlled, Parallel-group Trial to Investigate the Efficacy and Safety of Different Intra Articular (i.a.) Dosages of Sprifermin in Subjects With Primary Osteoarthritis of the Knee
INTERVENTIONAL
Inicio: 29 de jul de 2013
ID: NCT01919164
Completado
Fase 1
ClinicalTrials.gov
A Phase Ib, Open-Label, Multicenter Study to Investigate the Pharmacokinetics, Pharmacodynamics, and Safety of Tocilizumab Following Subcutaneous Administration to Patients With Polyarticular Juvenile Idiopathic Arthritis
INTERVENTIONAL
Inicio: 1 de jul de 2013
ID: NCT01904279
Terminado
Fase 2
ClinicalTrials.gov
Assessment of Safety and Efficacy of BG9924 in Subjects With RA Who Have Participated in Study 104RA202.
INTERVENTIONAL
Inicio: 1 de nov de 2007
ID: NCT00664573
Completado
Fase 2
ClinicalTrials.gov
A Phase 2B, Randomized, Double Blind, Placebo-Controlled, Multicenter Study To Compare 6 Dose Regimens Of CP-690,550 Vs. Placebo, Each Combined With Methotrexate, Administered For 6 Months In The Treatment Of Subjects With Active Rheumatoid Arthritis Who Have Had An Inadequate Response To Methotrexate Alone
INTERVENTIONAL
Inicio: 1 de ene de 2007
ID: NCT00413660
Completado
ClinicalTrials.gov
A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab)
OBSERVATIONAL
Inicio: 21 de feb de 2013
ID: NCT01729455
Completado
Fase 3
ClinicalTrials.gov
A Single-arm, Open-label Study of the Safety and Reduction of Signs and Symptoms During Treatment With Tocilizumab in Combination With Methotrexate, in Patients With Moderate to Severe Active Rheumatoid Arthritis
INTERVENTIONAL
Inicio: 1 de feb de 2009
ID: NCT00754572
Completado
Fase 3
ClinicalTrials.gov
A Phase 3B, Randomized, Double-Blind Clinical Trial to Evaluate the Efficacy and Safety of Abatacept SC in Combination With Methotrexate Compared to Methotrexate Monotherapy in Achieving Clinical Remission in Adults With Early Rheumatoid Arthritis Who Are Methotrexate Naive
INTERVENTIONAL
Inicio: 3 de sept de 2015
ID: NCT02504268
Activo, no recluta
Fase 2
ClinicalTrials.gov
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of HZN-1116 in Participants With Sjögren's Syndrome
INTERVENTIONAL
Inicio: 9 de may de 2024
ID: NCT06312020
Anterior
1
...
19
20
21
...
434
Siguiente
Filtros